Proteolytic Enzymes and Their Inhibition in Epithelial Ovarian Cancer

Author(s): A. McDonnel Smedts, T. E. Curry Jr., W. J. Murdoch

Journal Name: Current Enzyme Inhibition

Volume 1 , Issue 2 , 2005

Become EABM
Become Reviewer
Call for Editor


Common (surface) epithelial cancer of the ovary is epitomized by metastasis to organs of the abdominal cavity. Proteolytic enzymes, predominately those of the matrix metalloproteinase and plasminogen activator-plasmin systems, have been implicated as mediators of tissue invasion. This review highlights the salient features of ovarian cancer progression, the proteases involved, and experimental approaches of inhibition. Enzyme inhibitors hold promise in the treatment of early-stage and recurrent (following cytoreductive surgery) disease.

Keywords: matrix metalloproteinase, urokinase, kallikrein, ovarian cancer, protease inhibitor

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2005
Page: [157 - 170]
Pages: 14
DOI: 10.2174/1573408054022199
Price: $65

Article Metrics

PDF: 2